Montana Code 50-32-225. Criteria for placement of drug in Schedule III
Current as of: 2023 | Check for updates
|
Other versions
50-32-225. Criteria for placement of drug in Schedule III. The board shall place a drug in Schedule III if it finds that:
Terms Used In Montana Code 50-32-225
- Board: means the board of pharmacy provided for in 2-15-1733. See Montana Code 50-32-101
- United States: includes the District of Columbia and the territories. See Montana Code 1-1-201
(1)the drug has a potential for abuse less than the drugs listed in Schedules I and II;
(2)the drug has currently accepted medical use in treatment in the United States; and
(3)abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.